An asymmetric model of heterozygote advantage at major histocompatibility complex genes: Degenerate pathogen recognition and intersection advantage

Genetics

Volumn 178, Issue 3, 2008, Pages 1473-1489

  Stoffels, Rick J ^a,b   Spencer, Hamish G ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MURRAY DARLING FRESHWATER RESEARCH CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN;

ARTICLE; CORRELATION ANALYSIS; DNA POLYMORPHISM; GENE INTERACTION; GENE LOCUS; GENOTYPE; HETEROZYGOTE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; GENETIC DRIFT; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETICS; HOMOZYGOTE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; T LYMPHOCYTE;

ANIMALS; GENETIC DRIFT; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HOST-PATHOGEN INTERACTIONS; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, GENETIC; POLYMORPHISM, GENETIC; SELECTION (GENETICS); T-LYMPHOCYTES;

EID: 45149090854     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.107.082131     Document Type: Article

References (67)

1. ABBAS, A. K., and A. H. LICHTMAN, 2006 Basic Immunology: Functions and Disorders of the Immune System. W. B. Saunders, Philadelphia.
2. BARBER, L. D., B. GILLECECASTRO, L. PERCIVAL, X. B. LI, C. CLAYBERGER et al., 1995 Overlap in the repertoires of peptides bound in-vivo by a group of related class-I Hla-B allotypes. Curr. Biol. 5: 179-190.
3. BERTONI, R., J. SIDNEY, P. FOWLER, R. W. CHESNUT, F. V. CHISARI et al., 1997 Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J. Clin. Invest. 100: 503-513.
4. BOON, A. C. M., G. DE MUTSERT, Y. M. F. GRAUS, R. A. M. FOUCHIER, K. SINTNICOLAAS et al., 2002 The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J. Virol. 76: 582-590.
5. BORGHANS, J. A. M., J. B. BELTMAN and R. J. DE BOER, 2004 MHC polymorphism under host-pathogen coevolution. Immunogenetics 55: 732-739.
6. BURROWS, S. R., R. A. ELKINGTON, J. J. MILES, K. J. GREEN, S. WALKER et al., 2003 Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype. J. Immunol. 171: 1407-1412.
7. CARRINGTON, M., G. W. NELSON, M. P. MARTIN, T. KISSNER, D. VLAHOV et al., 1999 HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283: 1748-1752.
8. CASTELLI, F. A., C. BUHOT, A. SANSON, H. ZAROUR, S. POUVELLE-MORATILLE et al., 2002 HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J. Immunol. 169: 6928-6934.
9. CHEN, W. S., S. KHILKO, J. FECONDO, D. H. MARGULIES and J. MCCLUSKEY, 1994 Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180: 1471-1483.
10. CONSUEGRA, S., H. J. MEGENS, H. SCHASCHL, K. LEON, R. J. M. STET et al., 2005 Rapid evolution of the MH class I locus results in different allelic compositions in recently diverged populations of Atlantic salmon. Mol. Biol. Evol. 22: 1095-1106.
11. CROTZER, V. L., R. E. CHRISTIAN, J. M. BROOKS, J. SHABANOWITZ, R. E. SETTLAGE et al., 2000 Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines. J. Immunol. 164: 6120-6129.
12. CROW, J. F., and A. M. KIMURA, 1970 An Introduction to Population Genetics Theory. Harper & Row, New York.
13. DE BOER, R. J., J. A. M. BORGHANS, M. VAN BOVEN, C. KESMIR and F. J. WEISSING, 2004 Heterozygote advantage fails to explain the high degree of polymorphism of the MHC. Immunogenetics 55: 725-731.
14. DIAZ, G., B. CANAS, J. VAZQUEZ, C. NOMBELA and J. ARROYO, 2005 Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs. Immunogenetics 56: 754-759.
15. DOOLAN, D. L., S. L. HOFFMAN, S. SOUTHWOOD, P. A. WENTWORTH, J. SIDNEY et al., 1997 Degenerate cytotoxic T cell epitopes from P-falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity 7: 97-112.
16. DOOLAN, D. L., S. SOUTHWOOD, R. CHESNUT, E. APPELLA, E. GOMEZ et al., 2000 HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165: 1123-1137.
17. DOOLAN, D. L., S. SOUTHWOOD, D. A. FREILICH, J. SIDNEY, N. L. GRABER et al., 2003 Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 100: 9952-9957.
18. EWENS, W. J., 2004 Mathematical Population Genetics. I. Theoretical Introduction. Springer-Verlag, New York.
19. FROESCHKE, G., and S. SOMMER, 2005 MHC class II DRB variability and parasite load in the striped mouse (Rhabdomys pumilio) in the southern Kalahari. Mol. Biol. Evol. 22: 1254-1259.
20. GENTLE, J. E., 2003 Random Number Generation and Monte Carlo Methods. Springer-Verlag, New York.
21. GIANFRANI, C., C. OSEROFF, J. SIDNEY, R. W. CHESNUT and A. SETTE, 2000 Human memory CTL response specific for influenza A virus is broad and multispecific. Hum. Immunol. 61: 438-452.
22. HEDRICK, P. W., 2002 Pathogen resistance and genetic variation at MHC loci. Evolution 56: 1902-1908.
23. JAMESON, J., J. CRUZ and F. A. ENNIS, 1998 Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J. Virol. 72: 8682-8689.
24. JEFFERY, K. J. M., and C. R. M. BANGHAM, 2000 Do infectious diseases drive MHC diversity? Microbes Infect. 2: 1335-1341.
25. JEFFERY, K. J. M., A. A. SIDDIQUI, M. BUNCE, A. L. LLOYD, A. M. VINE et al., 2000 The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type T infection. J. Immunol. 165: 7278-7284.
26. KAST, W. M., R. M. P. BRANDT, J. SIDNEY, J. W. DRIJFHOUT, R. T. KUBO et al., 1994 Role of Hla-a motifs in identification of potential Ctl epitopes in human papillomavirus type-16 E6 and E7 proteins. J. Immunol. 152: 3904-3912.
27. KHANNA, R., S. R. BURROWS, J. NICHOLLS and L. M. POULSEN, 1998 Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 28: 451-458.
28. KIMURA, M., and J. F. CROW, 1964 Number of alleles that can be maintained in a finite population. Genetics 49: 725-738.
29. KOZIEL, M. J., D. DUDLEY, N. AFDHAL, A. GRAKOUI, C. M. RICE et al., 1995 Hla class I-restricted cytotoxic T-lymphocytes specific for hepatitis-C virus: identification of multiple epitopes and characterization of patterns of cytokine release. J. Clin. Invest. 96: 2311-2321.
30. LEWONTIN, R. C., L. R. GINZBURG and S. D. TULJAPURKAR, 1978 Heterosis as an explanation for large amounts of genic polymorphism. Genetics 88: 149-169.
31. MARKS, R. W., and H. G. SPENCER, 1991 The maintenance of singlelocus polymorphism. 2. The evolution of fitnesses and allele frequencies. Am. Nat. 138: 1354-1371.
32. MARTINSOHN, J. T., A. B. SOUSA, L. A. GUETHLEIN and J. C. HOWARD, 1999 The gene conversion hypothesis of MHC evolution: a review. Immunogenetics 50: 168-200.
33. MARUYAMA, T., and M. NEI, 1981 Genetic variability maintained by mutation and over-dominant selection in finite populations. Genetics 98: 441-459.
34. MCCLELLAND, E. E., D. J. PENN and W. K. POTTS, 2003 Major histocompatibility complex heterozygote superiority during coinfection. Infect, Immun. 71: 2079-2086.
35. NAYERSINA, R., P. FOWLER, S. GUILHOT, G. MISSALE, A. CERNY et al., 1993 Hla A2 restricted cytotoxic T-lymphocyte responses to multiple hepatitis-B surface-antigen epitopes during hepatitis-B virus-infection. J. Immunol. 150: 4659-4671.
36. NIKOLICH-ŽUGICH, J., D. H. FREMONT, M. J. MILEY and I. MESSAOUDI, 2004 The role of MHC polymorphism in anti-microbial resistance. Microbes Infect. 6: 501-512.
37. OHTA, T., 1999 Effect of gene conversion on polymorphic patterns at major histocompatibility complex loci. Immunol. Rev. 167: 319-325.
38. PANINA-BORDIGNON, P., A. TAN, A. TERMIJTELEN, S. DEMOTZ, G. CORRADIN et al., 1989 Universally immunogenic T-cell epitopes: promiscuous binding to human MHC class-Ii and promiscuous recognition by T-cells. Eur. J. Immunol. 19: 2237-2242.
39. PENN, D. J., K. DAMJANOVICH and W. K. POTTS, 2002 MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc. Natl. Acad. Sci. USA 99: 11260-11264.
40. REHERMANN, B., P. FOWLER, J. SIDNEY, J. PERSON, A. REDEKER et al., 1995 The cytotoxic T-lymphocyte response to multiple hepatitis-B virus polymerase epitopes during and after acute viral-hepatitis. J. Exp. Med. 181: 1047-1058.
41. REUSCH, T. B. H., and A. LANGEFORS, 2005 Inter- and intralocus recombination drive MHC class IIB gene diversification in a teleost, the three-spined stickleback Gasterosteus aculeatus. J. Mol. Evol. 61: 531-545.
42. RICHMAN, A. D., L. G. HERRERA, D. NASH and M. H. SCHIERUP, 2003 Relative roles of mutation and recombination in generating allelic polymorphism at an MHC class II locus in Peromyseus maniculatus. Genet. Res. 82: 89-99.
43. ROWLAND-JONES, S. L., T. DONG, K. R. FOWKE, J. KIMANI, P. KRAUSA et al., 1998 Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J. Clin. Invest. 102: 1758-1765.
44. SAUERMANN, U., P. NURNBERG, F. B. BERCOVITCH, J. D. BERARD, A. TREFILOV et al., 2001 Increased reproductive success of MHC class II heterozygous males among free-ranging rhesus macaques. Hum. Genet. 108: 249-254.
45. SCHASCHL, H., P. WANDELER, F. SUCHENTRUNK, G. OBEXER-RUFF and S. J. GOODMAN, 2006 Selection and recombination drive the evolution of MHC class II DRB diversity in ungulates. Heredity 97: 427-437.
46. SCHULZE ZUR WIESCH, J. S., G. M. LAUER, C. L. DAY, A. Y. KIM, K. OUCHI et al., 2005 Broad repertoire of the CD4(+) Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J. Immunol. 175: 3603-3613.
47. SCOTT, C. A., P. A. PETERSON, L. TEYTON and I. A. WILSON, 1998 Crystal structures of two I-A(d)-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8: 319-329.
48. SETTE, A., and J. SIDNEY, 1998 HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr. Opin. Immunol. 10: 478-482.
49. SIDNEY, J., M. F. DELGUERCIO, S. SOUTHWOOD, V. H. ENGELHARD, E. APPELLA et al., 1995 Several Hla alleles share overlapping peptide specificities. J. Immunol. 154: 247-259.
50. SIDNEY, J., H. M. GREY, R. T. KUBO and A. SETTE, 1996 Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17: 261-266.
51. SIDNEY, J., S. SOUTHWOOD, D. L. MANN, M. A. FERNANDEZ-VINA, M. J. NEWMAN et al., 2001 Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum. Immunol. 62: 1200-1216.
52. SIDNEY, J., S. SOUTHWOOD and A. SETTE, 2005 Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires. Immunogenetics 57: 393-408.
53. SINIGAGLIA, F., M. GUTTINGER, J. KILGUS, D. M. DORAN, H. MATILE et al., 1988 A malaria T-cell epitope recognized in association with most mouse and human MHC class-Ii molecules. Nature 336: 778-780.
54. SOUTHWOOD, S., J. SIDNEY, A. KONDO, M. F. DEL GUERCIO, E. APPELLA et al., 1998 Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. 160: 3363-3373.
55. SPENCER, H. G., and R. W. MARKS, 1988 The maintenance of single-locus polymorphism. I. Numerical studies of a viability selection model. Genetics 120: 605-613.
56. SPENCER, H. G., and R. W. MARKS, 1992 The maintenance of singlelocus polymorphism. IV. Models with mutation from existing alleles. Genetics 130: 211-221.
57. SPENCER, H. G., and R. W. MARKS, 1993 The evolutionary construction of molecular polymorphisms. N.Z. J. Bot. 31: 249-256.
58. TAKAHATA, N., and M. NEI, 1990 Allelic genealogy under over-dominant and frequency-dependent selection and polymorphism of major histocompatibility complex loci. Genetics 124: 967-978.
59. TAKAHATA, N., Y. SATTA and J. KLEIN, 1992 Polymorphism and balancing selection at major histocompatibility complex loci. Genetics 130: 925-938.
60. TANG, J. M., C. COSTELLO, I. P. M. KEET, C. RIVERS, S. LEBLANC et al., 1999 HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type I infection. Aids Res. Hum. Retroviruses 15: 317-324.
61. THIMME, R., K. M. CHANG, J. PEMBERTON, A. SETTE and F. V. CHISARI, 2001 Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51. J. Virol. 75: 3984-3987.
62. THURSZ, M. R., H. C. THOMAS, B. M. GREENWOOD and A. V. S. HILL, 1997 Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat. Genet. 17: 11-12.
63. TRACHTENBERG, E., B. KORBER, C. SOLLARS, T. B. KEPLER, P. T. HRABER et al., 2003 Advantage of rare HLA supertype in HIV disease progression. Nat. Med. 9: 928-935.
64. TYNAN, F. E., D. ELHASSEN, A. W. PURCELL, J. M. BURROWS, N. A. BORG et al., 2005 The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J. Exp. Med. 202: 1249-1260.
65. WEDEKIND, C., M. WALKER and T. J. LITTLE, 2005 The course of malaria in mice: major histocompatibility complex (MHC) effects, but no general MHC heterozygote advantage in single-strain infections. Genetics 170: 1427-1430.
66. WEDEKIND, C., M. WALKER and T. J. LITTLE, 2006 The separate and combined effects of MHC genotype, parasite clone, and host gender on the course of malaria in mice. BMC Genet. 7: 55.
67. YEWDELL, J. T., and J. R. BENNINK, 1999 Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17: 51-88.